Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × Neurofibroma × Clear all

NCT01275586 2017-04-12

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase EARLY_PHASE1 Completed

6 enrolled 7 charts

Neurofibroma, Neurofibromatoses, Neurofibroma, Plexiform

NCT00657202 2016-07-07

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Phase EARLY_PHASE1 Completed

Neurofibroma, Neurofibromatosis 1